Stay updated with breaking news from Brigitte Keller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Apogenix AG / Key word(s): Scientific publication Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model 01.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Apogenix’ new CD40 agonist...
EQS-News: Apogenix AG / Key word(s): Study/Study results Apogenix' Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept
EQS-News: Vakzine Projekt Management GmbH / Key word(s): Study results VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG 25.01.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. VPM ov...
EQS-News: Vakzine Projekt Management GmbH / Key word(s): Study results VPM oversees clinical trial and translational project management - Positive Phase I data of client Memo Therapeutics
EQS-News: HepaRegeniX GmbH / Key word(s): Personnel HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor 23.11.2022 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor Tübingen (Germany), November 2...